(-)-Epigallocatechin

(-)-Epigallocatechin is a lipid of Polyketides (PK) class. The involved functions are known as Protective Agents, inhibitors, Process, Drug Kinetics and Fermentation. (-)-epigallocatechin often locates in Hepatic, Blood, Membrane, Back and apical membrane. The associated genes with (-)-Epigallocatechin are ADRBK1 gene and FASTK Gene. The related lipids are 1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol. The related experimental models are Rodent Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of (-)-Epigallocatechin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (-)-Epigallocatechin?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (-)-Epigallocatechin

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Diseases D008107 31 associated lipids
Hemolysis D006461 131 associated lipids
Glioblastoma D005909 27 associated lipids
Body Weight D001835 333 associated lipids
Adenocarcinoma D000230 166 associated lipids
Total 8

PubChem Associated disorders and diseases

What pathways are associated with (-)-Epigallocatechin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (-)-Epigallocatechin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (-)-Epigallocatechin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (-)-Epigallocatechin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (-)-Epigallocatechin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (-)-Epigallocatechin?

Rodent Model

Rodent Model are used in the study 'Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing.' (Cox CJ et al., 2015) and Rodent Model are used in the study 'Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.' (Chow HH et al., 2005).

Transgenic Model

Transgenic Model are used in the study 'Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing.' (Cox CJ et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with (-)-Epigallocatechin

Download all related citations
Per page 10 20 50 100 | Total 933
Authors Title Published Journal PubMed Link
Zor M et al. Antigenotoxic properties of Paliurus spina-christi Mill fruits and their active compounds. 2017 BMC Complement Altern Med pmid:28446228
Pajonk F et al. The effects of tea extracts on proinflammatory signaling. 2006 BMC Med pmid:17140430
Li Y et al. Epigenetic regulation of caloric restriction in aging. 2011 BMC Med pmid:21867551
Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. 2009 BMC Med Genomics pmid:19133145
Shen CL et al. Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial. 2009 BMC Musculoskelet Disord pmid:19732445
Wei IH et al. (-)-Epigallocatechin gallate attenuates NADPH-d/nNOS expression in motor neurons of rats following peripheral nerve injury. 2011 BMC Neurosci pmid:21627848
Garbacki N et al. Inhibitory effects of proanthocyanidins from Ribes nigrum leaves on carrageenin acute inflammatory reactions induced in rats. 2004 BMC Pharmacol. pmid:15498105
Tsuneki H et al. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. 2004 BMC Pharmacol. pmid:15331020
Ali MB et al. Berry skin development in Norton grape: distinct patterns of transcriptional regulation and flavonoid biosynthesis. 2011 BMC Plant Biol. pmid:21219654
Huang YF et al. Dissecting genetic architecture of grape proanthocyanidin composition through quantitative trait locus mapping. 2012 BMC Plant Biol. pmid:22369244
Grabber JH et al. Identifying new lignin bioengineering targets: 1. Monolignol-substitute impacts on lignin formation and cell wall fermentability. 2010 BMC Plant Biol. pmid:20565789
Salucci M et al. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). 2002 Br. J. Cancer pmid:12085217
Scandlyn MJ et al. A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. 2008 Br. J. Cancer pmid:18797454
Renouf M et al. Plasma appearance and correlation between coffee and green tea metabolites in human subjects. 2010 Br. J. Nutr. pmid:20691128
Gregersen NT et al. Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions. 2009 Br. J. Nutr. pmid:19445822
Young JF et al. Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet. 2002 Br. J. Nutr. pmid:12064344
Xu JZ et al. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. 2004 Br. J. Nutr. pmid:15182391
Brown AL et al. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. 2011 Br. J. Nutr. pmid:21736785
Lu LH et al. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK. 1998 Br. J. Pharmacol. pmid:9720795
Naftalin RJ et al. Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. 2003 Br. J. Pharmacol. pmid:12970085
Anger DL et al. Heteroactivation of cytochrome P450 1A1 by teas and tea polyphenols. 2005 Br. J. Pharmacol. pmid:15895106
Zhang B et al. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. 2008 Brain Res. pmid:18255049
Koh SH et al. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. 2003 Brain Res. Mol. Brain Res. pmid:14559356
Wang ZG et al. Effect of supplementation of green tea polyphenols on the developmental competence of bovine oocytes in vitro. 2007 Braz. J. Med. Biol. Res. pmid:17665044
Liu B et al. ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation. 2010 Breast Cancer Res. pmid:20096139
Limer JL and Speirs V Phyto-oestrogens and breast cancer chemoprevention. 2004 Breast Cancer Res. pmid:15084232
Luo T et al. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. 2010 Breast Cancer Res. pmid:20078855
Vergote D et al. (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. 2002 Breast Cancer Res. Treat. pmid:12462380
Luo J et al. Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. 2010 Breast Cancer Res. Treat. pmid:19653095
Iwasaki M et al. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. 2010 Breast Cancer Res. Treat. pmid:20440552
Ando T et al. Effects of tea catechins on cholesterol absorption with exogenously hypercholesterolemic rat (ExHC-Ta). 1989 Bull Kanagawa Dent Coll pmid:2519221
Bouhamidi R et al. High protection by grape seed proanthocyanidins (GSPC) of polyunsaturated fatty acids against UV-C induced peroxidation. 1998 C. R. Acad. Sci. III, Sci. Vie pmid:9759355
Evensen NA and Braun PC The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation. 2009 Can. J. Microbiol. pmid:19898545
Das A et al. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. 2010 Cancer pmid:19894226
Eto I "Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells". 2006 Cancer Cell Int. pmid:16899133
Belkaid A et al. The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. 2006 Cancer Cell Int. pmid:16566826
Sasazuki S et al. Plasma tea polyphenols and gastric cancer risk: a case-control study nested in a large population-based prospective study in Japan. 2008 Cancer Epidemiol. Biomarkers Prev. pmid:18268118
Yang CS et al. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. 1999 Cancer Epidemiol. Biomarkers Prev. pmid:9950244
Chow HH et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. 2001 Cancer Epidemiol. Biomarkers Prev. pmid:11205489
Lee MJ et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. 2002 Cancer Epidemiol. Biomarkers Prev. pmid:12376503
Lin SC et al. The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells. 2006 Cancer Lett. pmid:15975707
Taniguchi S et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. 1992 Cancer Lett. pmid:1511409
Günther S et al. Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells. 2007 Cancer Lett. pmid:17070989
Kennedy DO et al. Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin. 2002 Cancer Lett. pmid:11880178
Lee MH et al. EBV DNA polymerase inhibition of tannins from Eugenia uniflora. 2000 Cancer Lett. pmid:10806300
Kuzuhara T et al. Green tea catechin as a chemical chaperone in cancer prevention. 2008 Cancer Lett. pmid:18068893
Tan X et al. Differences of four catechins in cell cycle arrest and induction of apoptosis in LoVo cells. 2000 Cancer Lett. pmid:10940502
Pavese JM et al. Inhibition of cancer cell invasion and metastasis by genistein. 2010 Cancer Metastasis Rev. pmid:20730632
Wang P et al. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. 2010 Cancer Prev Res (Phila) pmid:20628004
Bode AM and Dong Z Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail. 2009 Cancer Prev Res (Phila) pmid:19470792